|

Kevin Van
Paassen,
National Post
Dr.
Raymond Reilly, a nuclear pharmacist, is one of two scientists
who have been awarded $25,000 grants through Toronto's Hospital
for Sick Children for research into neuroblastoma tumours.
|
June 20, 2001
Research
fast-tracked for boy dying of cancer
Likely too late for seven-year-old James Birrell
Heather Sokoloff
National Post
The Hospital for Sick
Children has awarded two $25,000 grants for research into a rare
cancer using funds raised by the community of a boy who is dying
of the disease.
The grants have been
fast-tracked by the hospital so the research can begin immediately.
"I've never seen anything
like this. The breadth and scope of it is quite remarkable," said
Malcolm Burrows, a director at the hospital's charitable foundation.
"There's always that
sense there's this long and elaborate process. It takes months
and months and months to do it. This was very unusual," Mr. Burrows
added.
The funds were raised
largely in $10 and $20 donations from residents of Peterborough,
where the young cancer patient, James Birrell, lives.
Yesterday, the seven-year-old,
who suffers from neuroblastoma, telephoned Raymond Reilly, a nuclear
pharmacist, to congratulate him on his grant. "I hope your research
is able to help children," James told Dr. Reilly.
Dr. Reilly is one of
only a few nuclear pharmacists in Canada able to prepare a radioactive
mixture to see where the neuroblastoma tumours that attack the
central nervous system are growing in children's bodies.
He will experiment
with increasing the amounts of the radioactive ingredients he
uses to detect the tumours in an effort to attack the cancer cells,
a process that has been successful in his previous research on
breast cancer.
The other $25,000 grant
is going to Jeremy Squire, a molecular biologist at the Ontario
Cancer Institute, who has been using DNA information found in
the Human Genome Project to see if genetic factors are to blame
for the low success rate in treating neuroblastoma tumours.
He examines DNA in
tumours surgically removed from patients. The process costs his
lab $600 a tumour.
Although the Hospital
for Sick Children accelerated the normally time-consuming process
of doling out money collected through charitable donations, the
results of Dr. Reilly's and Dr. Squire's work will likely come
too late for James.
The boy has been near
death six times since he was diagnosed with cancer at the age
of four. Each time, he managed to beat the odds by bouncing back,
even after cardiac arrest.
But last month, he
relapsed again when the cancer moved to his brain.
He could die any day.
Dr. Reilly, who has
met James and shown him cancer cells in his lab, is on an e-mail
list set up by James' father, Syd, who sends e-mails to tens of
thousands of people around the world with weekly updates on his
son's condition, posted at www.jamesbirrell.ca
"That never happened
to me before," said Dr. Reilly of the phone call from James, from
his lab at Toronto General Hospital, where he works as one of
only a handful of nuclear pharmacists in Canada.
"There is a movement
now to have researchers meet cancer patients, and so I've sat
next to breast cancer survivors at dinner fundraisers, but I've
never had one call me to wish me good luck with my research."
|